Bioventus Total Liab from 2010 to 2025

BVS Stock  USD 9.65  0.09  0.92%   
Bioventus Total Liabilities yearly trend continues to be comparatively stable with very little volatility. Total Liabilities will likely drop to about 535.2 M in 2025. Total Liabilities is the total amount of all liabilities that Bioventus has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2016-03-31
Previous Quarter
582.7 M
Current Value
542.4 M
Quarterly Volatility
205.4 M
 
Yuan Drop
 
Covid
Check Bioventus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioventus' main balance sheet or income statement drivers, such as Total Revenue of 411.2 M, Gross Profit of 303.8 M or Other Operating Expenses of 390.2 M, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 4.0E-4 or PTB Ratio of 5.28. Bioventus financial statements analysis is a perfect complement when working with Bioventus Valuation or Volatility modules.
  
Check out the analysis of Bioventus Correlation against competitors.
For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.

Latest Bioventus' Total Liab Growth Pattern

Below is the plot of the Total Liab of Bioventus over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Bioventus' Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bioventus' overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Bioventus Total Liab Regression Statistics

Arithmetic Mean407,555,439
Geometric Mean367,881,091
Coefficient Of Variation53.66
Mean Deviation169,246,478
Median297,456,000
Standard Deviation218,682,163
Sample Variance47821.9T
Range779.4M
R-Value0.71
Mean Square Error25457.9T
R-Squared0.50
Significance0
Slope32,580,999
Total Sum of Squares717328.3T

Bioventus Total Liab History

2025535.2 M
2024542.4 M
2023589.8 M
2022B
2021692.1 M
2020350.3 M
2019326.8 M

About Bioventus Financial Statements

Bioventus shareholders use historical fundamental indicators, such as Total Liab, to determine how well the company is positioned to perform in the future. Although Bioventus investors may analyze each financial statement separately, they are all interrelated. The changes in Bioventus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Bioventus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Liabilities542.4 M535.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Bioventus Stock Analysis

When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.